Scarica l'app Stockscreener
20.79
0.34%
-0.07
Dopo l'orario di chiusura:
20.79
Precedente Chiudi:
$20.86
Aprire:
$20.9
Volume 24 ore:
823.73K
Relative Volume:
0.72
Capitalizzazione di mercato:
$2.66B
Reddito:
$2.25B
Utile/perdita netta:
$27.39M
Rapporto P/E:
123.90
EPS:
0.1678
Flusso di cassa netto:
$136.77M
1 W Prestazione:
-1.56%
1M Prestazione:
-16.27%
6M Prestazione:
-12.46%
1 anno Prestazione:
-4.68%
Intervallo 1D:
$20.70
$21.25
Intervallo di 1 settimana:
$20.70
$21.49
Portata 52W:
$19.53
$28.82
Privia Health Group Inc Stock (PRVA) Company Profile
Nome
Privia Health Group Inc
Settore
Industria
Telefono
571-366-8850
Indirizzo
950 N. GLEBE RD., SUITE 700, ARLINGTON
Compare PRVA vs VEEV, BTSG, TEM, HQY, TXG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
20.79 | 2.71B | 2.25B | 27.39M | 136.77M | 0.1678 |
VEEV
Veeva Systems Inc
|
276.69 | 40.70B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
59.13 | 11.78B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
64.04 | 12.03B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
96.37 | 8.72B | 1.34B | 230.70M | 440.96M | 2.6695 |
TXG
10 X Genomics Inc
|
61.54 | 8.32B | 638.78M | -22.66M | 122.18M | -0.1744 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-11-13 | Iniziato | BMO Capital Markets | Outperform |
| 2025-01-10 | Iniziato | Needham | Buy |
| 2024-12-16 | Iniziato | Macquarie | Outperform |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-04-22 | Iniziato | Citigroup | Buy |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Ripresa | Jefferies | Buy |
| 2024-02-22 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-12-06 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-06-13 | Iniziato | Evercore ISI | Outperform |
| 2023-04-12 | Iniziato | Stephens | Overweight |
| 2023-03-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-02-03 | Iniziato | Goldman | Buy |
| 2022-12-09 | Iniziato | Stifel | Buy |
| 2022-12-08 | Iniziato | UBS | Buy |
| 2022-09-07 | Ripresa | Truist | Buy |
| 2022-05-03 | Iniziato | BofA Securities | Buy |
| 2022-04-28 | Iniziato | BTIG Research | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-30 | Iniziato | Guggenheim | Buy |
| 2022-02-22 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2022-01-03 | Iniziato | Jefferies | Buy |
| 2021-09-27 | Iniziato | SVB Leerink | Outperform |
| 2021-09-10 | Iniziato | Cowen | Market Perform |
| 2021-05-24 | Iniziato | Canaccord Genuity | Buy |
| 2021-05-24 | Iniziato | Credit Suisse | Outperform |
| 2021-05-24 | Iniziato | JP Morgan | Overweight |
| 2021-05-24 | Iniziato | Piper Sandler | Overweight |
| 2021-05-24 | Iniziato | Truist | Buy |
| 2021-05-24 | Iniziato | William Blair | Outperform |
Mostra tutto
Privia Health Group Inc Borsa (PRVA) Ultime notizie
Privia Health (PRVA): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
Should Stronger 2026 Guidance and New Board Expertise Require Action From Privia Health Group (PRVA) Investors? - simplywall.st
PRVA Q2 2026 Earnings: Modest EPS Beat Signals Steady Execution in Value-Based CareManagement Tone Analysis - vinanet.vn
Privia Health Appoints Dr. Opella Ernest to Board of Directors Effective September 2026 - Kalkine Media
Privia Health adds Dr. Opella Ernest to board of directors - Investing.com
Privia Health adds Dr. Opella Ernest to board of directors By Investing.com - Investing.com Nigeria
Form 8K Privia Health Group Inc For: 18 August By Investing.com - Investing.com Nigeria
Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors - The Manila Times
Privia Health Group Appoints Opella Ernest, M.D. to Board of Directors - Quiver Quantitative
A 20-year healthcare executive is set to join Privia Health's board - Stock Titan
Privia (PRVA) Erases Recent Gains with -2.27% Plunge 2026-08-18Donchian Channel - vinanet.vn
Bank of America Corp DE Cuts Holdings in Privia Health Group, Inc. $PRVA - MarketBeat
Privia Health (PRVA) Edges Higher to $22.0, Holding Above Key SupportTotal Put Call - vinanet.vn
GSA Capital Partners LLP Invests $1.67 Million in Privia Health Group, Inc. $PRVA - MarketBeat
OneDigital Investment Advisors LLC Purchases New Stake in Privia Health Group, Inc. $PRVA - MarketBeat
ETFs Investing in Privia Health Group, Inc. Stocks - TradingView
Oppenheimer Asset Management Inc. Purchases New Stake in Privia Health Group, Inc. $PRVA - MarketBeat
PRVA|Privia Health Group Inc|Price:22.000|Chg%:+0.240 - TradingKey
Privia Health (PRVA) Climbs 1.1% to $22.0, Testing Key Resistance at $23.1Standard Deviation - vinanet.vn
The Top 5 Analyst Questions From Privia Health’s Q2 Earnings Call - Yahoo Finance
Privia Health’s (PRVA) Guidance Keeps Rising, So Is The Stock Keeping Pace? - Yahoo Finance
Privia Health Group, Inc. (PRVA) Stock Forecasts - Yahoo! Finance Canada
Privia Health (PRVA) Q2 2026 Earnings Call Transcript - The Globe and Mail
(PRVA) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
PRVA Q2 2026 Earnings: EPS Beats Estimates Modestly While Stock SlipsEarnings Sentiment Score - vinanet.vn
Privia Health Group, Inc. (PRVA) Stock Analysis: A 41% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Privia Health Group (PRVA) Is Down 5.2% After Q2 Beat And Higher 2026 OutlookWhat's Changed - simplywall.st
Privia Health Group (PRVA) Is Down 5.2% After Raising 2026 Revenue Guidance And Expanding Footprint - Yahoo Finance
A Quick Look at Today's Ratings for Privia Health(PRVA.US), With a Forecast Between $30 to $36 - moomoo.com
BMO Capital Keeps Their Buy Rating on Privia Health Group (PRVA) - The Globe and Mail
Sei Investments Co. Cuts Stock Position in Privia Health Group, Inc. $PRVA - MarketBeat
Privia Health Group (PRVA) Stock Faces Cash Flow Questions After Guidance Lift - Sahm
Enterprise value to EBITDA forward of Privia Health Group, Inc. – NASDAQ:PRVA - TradingView
Enterprise value to EBIT forward of Privia Health Group, Inc. – NASDAQ:PRVA - TradingView
Privia Health Group (NASDAQ:PRVA) Stock Rating Upgraded by Zacks Research - MarketBeat
PRVA Q2 Deep Dive: Revenue Growth Outpaces Profit as Margin Expansion Remains in Focus - StockStory
Privia Health Group Q2 Earnings Call Highlights - MarketBeat
Privia Health (PRVA) Edges Higher as Shares Test Key Resistance ZonePCR Mean Reversion - vinanet.vn
Privia Health Group, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:PRVA) 2026-08-07 - Seeking Alpha
Privia Health Group Inc (PRVA) Stock Down 8.2% -- Now Undervalued? GF Score: 88/100 - GuruFocus
Form 8K Privia Health Group Inc For: 6 August By Investing.com - Investing.com Nigeria
PRVA Q2 FY2026 earnings call - finance.biggo.com
Earnings call transcript: Privia Health beats Q2 2026 estimates, shares fall - Investing.com Nigeria
Privia Health Group, Inc. Stock 12‑Month Price Target Cut to $31.78, Implies 33% Upside - TradingView
Privia Health Group Inc (PRVA) (Q2 2026) Earnings Call Highlights: Strong Growth and Raised ... - Yahoo Finance
Privia Health Group Reports Q2 2026 Financial Results in SEC Form 10-Q Filing - Kalkine Media
Privia Health Group Releases Q2 2026 Financial Results - AlphaStreet
Privia Health Group (NASDAQ:PRVA) Shares Gap DownShould You Sell? - MarketBeat
Privia Health beats Q2 estimates, issues 2026 guidance - Investing.com
Privia Health Shares Slide After Q2 Adjusted Earnings Miss - marketscreener.com
Privia Health releases transcript of 2Q 2026 conference call - Bitget
Privia Health Group Inc Azioni (PRVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.14%
4.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):